1 result(s) for
| PI Name | Protocol # | Title |
|---|---|---|
| Rebecca Silbermann | STUDY00018117 | A Phase 1/2a Open-label, Dose-Escalation Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Patients With Relapsed/Refractory Multiple Myeloma |